Cancer cell lines predict drug response, study showsJuly 8, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLALLCMLNon-Hodgkin Lymphoma
NHL patients may have higher risk of second cancerJuly 7, 2016Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
EC extends marketing authorization for brentuximab vedotinJuly 7, 2016Lymphoma & Plasma Cell DisordersPharmacyHodgkin Lymphoma
New type of CAR T cells can produce responses in NHLJuly 1, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaNon-Hodgkin Lymphoma
Combo shows promise for treating DLBCLJune 30, 2016Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Immunotherapy drugs linked to rheumatic diseasesJune 28, 2016Lymphoma & Plasma Cell DisordersRelated Issues
Team maps chromatin landscape in CLLJune 28, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
CHMP rejects ofatumumab as maintenanceJune 26, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Interim PET-CT can spare HL patients intensive chemoJune 23, 2016Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
Obinutuzumab approved to treat FLJune 19, 2016Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Drug can address unmet need in cHL, doc saysJune 18, 2016Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
HIV not a contraindication for transplant in lymphomaJune 17, 2016Lymphoma & Plasma Cell DisordersTransplantationHodgkin LymphomaNon-Hodgkin Lymphoma
Delaying therapy for HL/NHL likely safe for mom, babyJune 9, 2016Lymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin Lymphoma
Rituximab plus chemo in kids with B-NHL could be practice changingJune 8, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsNon-Hodgkin Lymphoma
